
CAS 1132709-14-8
:Fórmula:C19H25BN4O4
InChI:InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17+/m0/s1
Chave InChI:GXJABQQUPOEUTA-DOTOQJQBSA-N
SMILES:B([C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 9 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
CAS:Fórmula:C19H25BN4O4Pureza:98%Cor e Forma:SolidPeso molecular:384.2372(1S,2S)-Bortezomib
CAS:Produto ControladoImpurity Bortezomib USP Impurity G
Stability Hygroscopic
Applications (1S,2S)-Bortezomib is an isomer of Bortezomib (B675700), proteasome inhibitor. (1S,2S)-Bortezomib has been seen to inhibit serine proteases shown to lower cellular Aβ concentrations, associated with Alzheimer’s or hypertension.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Hardy, J. et al.: Science, 297, 353 (2002); Paris, D. et al.: Mol. Med. 17, 149 (2011);Fórmula:C19H25BN4O4Cor e Forma:NeatPeso molecular:384.24(1S,2S)-Bortezomib
CAS:((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acidFórmula:C19H25BN4O4Pureza:98%Peso molecular:384.24(1S,2S)-Bortezomib-d5
CAS:Produto ControladoFórmula:C19D5H20BN4O4Cor e Forma:NeatPeso molecular:389.268(1S,2S)-Bortezomib
CAS:(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib.Fórmula:C19H25BN4O4Pureza:99.6%Cor e Forma:SolidPeso molecular:384.24Ref: TM-T10061
1mg60,00€2mg92,00€5mg160,00€1mL*10mM (DMSO)163,00€10mg269,00€25mg429,00€50mg583,00€100mg783,00€







